Hi Skint,
Last weekend I was thinking about placebo effect and came across this Krismer et al (2022) review paper comparing UMSARS progression in natural history studies and placebo arms of RCTs. I'm not a stats guy and haven't looked deeply into each study, but what's encouraging I find is that the placebo effect looks low as placebo patients progress similar to natural history study patients in Table 2 - hopefully boding well for 201 read-out. Cheers
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9771866/
WTF !!!, page-23
Add ATH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.3¢ |
Change
-0.001(25.0%) |
Mkt cap ! $21.28M | |||
| Open | High | Low | Value | Volume |
| 0.3¢ | 0.3¢ | 0.3¢ | $3 | 1.02K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 36 | 21966467 | 0.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.4¢ | 133248494 | 35 |
View Market Depth
| Last trade - 13.52pm 10/10/2024 (20 minute delay) ? |
| ATH (ASX) Chart |